This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (683) #xTransplantation (1) Nephrology/Renal Disorders (99)

Published on in Vol 11, No 12 (2022): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41020, first published .
Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study

Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study

Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study

Authors of this article:

James N Fleming1 Author Orcid Image ;   Timothy Cober1 Author Orcid Image ;   Janelle Hickey1 Author Orcid Image ;   Leslie Stach1 Author Orcid Image ;   Allison Kawano1 Author Orcid Image ;   Amanda Szczepanik1 Author Orcid Image ;   Alicia Watson1 Author Orcid Image ;   Yuka Imamura1 Author Orcid Image ;   Juston Weems1 Author Orcid Image ;   Patricia West-Thielke1 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Lafont T, Mukhopadhyay S, Dassanayake S, Hernández-Fuentes M, Chowdhury P, Kassimatis T. Advances in biomarkers of acute allograft rejection and interstitial fibrosis/tubular atrophy in kidney transplantation; future perspective and challenges in clinical implementation. Transplantation Reviews 2025;39(3):100930 View
  2. Strader M, Kant S. Novel Biomarkers for Rejection in Kidney Transplantation: A Comprehensive Review. Journal of Clinical Medicine 2025;14(15):5489 View